Phase II multicenter trial of platinum-cetuximab combined with docetaxel or with 5FU for Japanese patients with recurrent/metastatic squamous cell carcinoma of the head and neck.
Phase of Trial: Phase II
Latest Information Update: 11 Dec 2017
At a glance
- Drugs Cetuximab (Primary) ; Cisplatin; Docetaxel; Fluorouracil
- Indications Head and neck cancer; Squamous cell cancer
- Focus Therapeutic Use
- Acronyms TEMPER study
- 08 Dec 2017 Status changed from not yet recruiting to recruiting.
- 28 Jun 2017 Planned initiation date changed from 1 May 2017 to 1 Aug 2017.
- 14 Apr 2017 Planned initiation date changed from 1 Feb 2017 to 1 May 2017.